Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
Seminars in Thrombosis and Hemostasis|April 9, 2008
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIaJob Harenberg, Martin WehlingCardiovascular Therapeutics|July 15, 2010
Future of anticoagulant therapyJob Harenberg, Martin WehlingBritish Journal of Pharmacology|July 12, 2011
New anticoagulants - promising and failed developmentsJob Harenberg, Svetlana Marx, Martin Krejczy, et al.MMW Fortschritte Der Medizin|July 9, 2015
[Development of a questionnaire to identify patients' preference for a conventional or a direct oral anticoagulant]Shabnam Zolfaghari, Job Harenberg, Martin Wehling, et al.Seminars in Thrombosis and Hemostasis|January 2, 2014
Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapyShabnam Zolfaghari, Job Harenberg, Lutz Froelich, et al.Journal of Thrombosis and Thrombolysis|August 4, 2011
Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variabilityJob Harenberg, Roland Krämer, Christina Giese, et al.Journal of Thrombosis and Thrombolysis|November 14, 2013
Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countriesMartin Krejczy, Job Harenberg, Svetlana Marx, et al.Seminars in Thrombosis and Hemostasis|February 16, 2015
Patients' serum and urine as easily accessible samples for the measurement of non-vitamin K antagonist oral anticoagulantsJob Harenberg, Shanshan Du, Sandra Krämer, et al.Therapeutic Drug Monitoring|December 20, 2014
Measurement of Non-Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation MethodShanshan Du, Job Harenberg, Sandra Krämer, et al.Biomed Research International|April 9, 2015
Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in GermanyMartin Krejczy, Job Harenberg, Martin Wehling, et al.Pageof 21